-
公开(公告)号:US20210341494A1
公开(公告)日:2021-11-04
申请号:US17361763
申请日:2021-06-29
发明人: Sid E. O'Bryant , Leigh A. Johnson
摘要: The present invention includes methods for selecting a therapy for improved cognition as well as prevention of cognitive loss/dysfunction using one or more endophenotypes comprising: obtaining a sample from a subject; measuring biomarkers that differentiate between an inflammatory, a metabolic, a neurotrophic, and a depressive endophenotype; and selecting a course of treatment for the subject based on whether the subject is scored as having a high or a low endophenotype for one or more of the inflammatory, a metabolic, a neurotrophic, and a depressive endophenotypes.